Corticotropin-releasing hormone stimulates NF-κB in human epidermal keratinocytes

Journal of Endocrinology

Volumn 181, Issue 3, 2004, Pages

  Zbytek, Blazej ^a,b   Pfeffer, Lawrence M ^a   Slominski, Andrzej T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTALARMIN; CHLORAMPHENICOL ACETYLTRANSFERASE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN INHIBITOR; PROTEIN SUBUNIT; SYNAPTOTAGMIN;

ALPHA HELIX; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; ENZYME ACTIVITY; EPIDERMIS CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REPORTER GENE;

EID: 3042808577     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.181R001     Document Type: Article

References (33)

1. Barker JN, Mitra RS, Griffiths CE, Dixit VM & Nickoloff BJ 1991 Keratinocytes as initiators of inflammation. Lancet 337 211-214.
2. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO & Nickoloff BJ 1999 Apoptosis in proliferating, senescent, and immortalized keratinocytes. Journal of Biological Chemistry 274 23358-23367.
3. Chrousos GP & Gold PW 1992 The concepts of stress and stress system disorders. Journal of the American Medical Association 267 1244-1252.
4. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y & Khavari PA 2003 NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421 639-643.
5. Fazal N, Slominski A, Choudhry MA, Wei ET & Sayeed MM 1998 Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Letters 435 187-190.
6. Freedberg IM, Tomic-Canic M, Komine M & Blumenberg M 2001 Keratins and the keratinocyte activation cycle. Journal of Investigative Dermatology 116 633-640.
7. Hagan P, Poole S & Bristow AF 1992 Immunosuppresive activity of corticotropin-releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells. Biochemical Journal 281 251-254.
8. Leu Sj & Singh VK 1992 Stimulation of interleukin-6 production by corticotropin-releasing factor. Cellular Immunology 143 220-227.
9. Lezoualc'h F, Engert S, Berning B & Behl C 2002 Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid β precursor protein and with the suppression of NF-κB. Molecular Endocrinology 14 147-159.
10. Li Q & Verma IM 2002 NF-κB regulation in the immune system. Nature Reviews. Immunology 2 725-734.
11. Mempel M, Voelcker V, Köllisch G, Plank C, Rad R, Gerhard Mi, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D & Ollert M 2003 Toll-like receptor expression in human keratinocytes: nuclear factor-κB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. Journal of Investigative Dermatology 121 1389-1396.
12. Pereda MP, Saucer J, Castro CP, Finkielman S, Stalla GK, Holsboer F & Arzt E 1995 Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 136 5504-5510.
13. Pisarchik A & Slominski AT 2001 Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB Journal 15 2754-2756.
14. Quevedo ME, Slominski A, Pinto W, Wei E & Wortsman J 2001 Pleiotropic effects of corticotropin-releasing hormone on normal human skin keratinocytes. In Vitro Cellular and Developmental Biology. Animal 37 50-54.
15. Qin JZ, Bacon P, Chaturvedi V & Nickoloff BJ 2001 Role of NF-κB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand. Journal of Investigative Dermatology 117 898-907.
16. Ray DW, Ren SG & Melmed S 1998 Leukemia inhibitory factor regulates pro-opiomelanocortin transcription. Annals of the New York Academy of Sciences 840 162-173.
17. Schallreuter KU 1997 Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis. Journal of Investigative Dermatology Symposium Proceedings 2 37-40.
18. Singh VK 1989 Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. Journal of Neuroimmunology 23 257-262.
19. Seitz CS, Deng H, Hinata K, Lin Q & Khavari PA 2000 Nuclear factor-κB subunits induce epithelial cell growth arrest. Cancer Research 60 4085-4092.
20. Singh VK & Leu SC 1990 Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neuroscience Letters 120 151-154.
21. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E et al. 1999 Cutaneous expression of CRH and CRH-R. Is there a 'skin stress response system? Annals of the New York Academy of Sciences 885 287-311.
22. Slominski A, Ermak G, Mazurkiewicz JE, Baker J & Wortsman J 1998 Characterization of corticotropin-releasing hormone (CRH) in human skin. Journal of Clinical Endocrinology and Metabolism 83 1020-1024.
23. Slominski AT, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J & Wortsman J 2000a Corticotropin-releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cellular and Developmental Biology. Animal 36 211-216.
24. Slominski A, Szczesniewski A & Wortsman J 2000b Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. Journal of Clinical Endocrinology and Metabolism 85 3582-3588.
25. Slominski A & Wortsman J 2000 Neuroendocrinology of the skin. Endocrine Reviews 21 457-487.
26. Slominski A, Wortsman J, Luger T, Paus R & Salomon S 2000c Corticotropin-releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiological Reviews 80 979-1020.
27. Slominski AT, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE & Wei ET 2001 Cutaneous expression of corticotropin releasing hormone (CRH), urocortin, and CRH receptors. FASEB Journal 15 1678-1693.
28. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E & Chrousos G 1998 Corticotropin releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 139 403-413.
29. Wiesner B, Roloff B, Fechner K & Slominski A 2003 Intracellular calcium measurements of single human skin cells after stimulation with corticotropin releasing factor and urocortin using confocal laser scanning microscopy. Journal of Cell Science 116 1261-268.
30. Yang CH, Murti A, Pfeffer SR, Basu L, Kim JG & Pfeffer LM 2000 IFN α/β promotes cell survival by activating NF-κ B. PNAS 97 13631-13636.
31. Zbytek B, Mysliwski A, Slominski A, Wortsman J, Wei ET & Mysliwska J 2002 Corticotropin releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sciences 70 1013-1021.
32. Zbytek B, Pfeffer LM & Slominski AT 2003 Corticotropin releasing hormone inhibits nuclear factor-κB pathway in human HaCaT keratinocytes. Journal of Investigative Dermatology 121 1496-1499.
33. Zhao J & Karalis K 2002 Regulation of nuclear factor-κB by corticotropin releasing hormone in mouse thymocytes. Molecular Endocrinology 16 2561-2570.